Seikagaku (4548) · InitiativeAdvanced
Expanding Single-Injection Products into New Markets through the Italian Launch of Hi-Link
First written in FY2019. 1 of 2 entries say "Advanced", first in FY2022. Latest entry: FY2022.
2entries
4years
0from disclosures
How it moved
Same theme, other companies
Expanding Single-Injection Products into New Markets through the Italian Launch of Hi-LinkA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2022AdvancedAnnual report
「In August 2021, we launched Yajie single-injection intra-articular injection (HyLink) in Taiwan and achieved a new out-licensing deal for a single-dose joint-function improvement agent.」
The company achieved the launch of HyLink in Taiwan in August 2021 as part of the expansion into new markets for single-dose products. - FY2019First statedAnnual report
「In pursuit of maximizing the value of single-dose products, we worked to enter new markets and achieved the launch of HyLink, a joint-function improvement agent, in Italy in March 2019.」
The company recorded for the first time the case of HyLink, a joint-function improvement agent, being launched in Italy in March 2019 as an example of expansion into new markets for single-dose products.